{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:36:50Z","timestamp":1791333410715,"version":"4.3.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.7759\/cureus.47088","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:27:12Z","timestamp":1697437632000},"source":"Crossref","is-referenced-by-count":2,"title":["Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal"],"prefix":"10.7759","author":[{"given":"Keisuke","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Ichiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Kashiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17r02185","article-title":"Neuroleptic malignant syndrome: Diagnosis and management","volume":"20","author":"Ware MR","year":"2018","unstructured":"Ware MR, Feller DB, Hall KL. Neuroleptic malignant syndrome: Diagnosis and management. Prim Care Companion CNS Disord. 2018, 20:17r02185. 10.4088\/PCC.17r02185","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn JR","year":"2007","unstructured":"Strawn JR, Keck PE, Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007, 164:870-6. 10.1176\/ajp.2007.164.6.870","journal-title":"Am J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06438","article-title":"An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method","volume":"72","author":"Gurrera RJ","year":"2011","unstructured":"Gurrera RJ, Caroff SN, Cohen A, et al.. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011, 72:1222-8. 10.4088\/JCP.10m06438","journal-title":"J Clin Psychiatry"},{"key":"ref4","article-title":"Recurrence of neuroleptic malignant syndrome","volume":"41","author":"Gonzalez-Blanco L","year":"2013","unstructured":"Gonzalez-Blanco L, Garcia-Prada H, Santamarina S, Jimenez-Trevino L, Bobes J. Recurrence of neuroleptic malignant syndrome. Actas Esp Psiquiatr. 2013, 41:314-8.","journal-title":"Actas Esp Psiquiatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00718","article-title":"Risperidone-associated neuroleptic malignant syndrome in an inpatient with schizophrenia, with successful rechallenge and 3 year follow-up","volume":"9","author":"Chen TR","year":"2018","unstructured":"Chen TR, Chen YC. Risperidone-associated neuroleptic malignant syndrome in an inpatient with schizophrenia, with successful rechallenge and 3 year follow-up. Front Psychiatry. 2018, 9:718. 10.3389\/fpsyt.2018.00718","journal-title":"Front Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/a-1046-1044","article-title":"Treatment of the neuroleptic malignant syndrome in international therapy guidelines: A comparative analysis","volume":"53","author":"Sch\u00f6nfeldt-Lecuona C","year":"2020","unstructured":"Sch\u00f6nfeldt-Lecuona C, Kuhlwilm L, Cronemeyer M, et al.. Treatment of the neuroleptic malignant syndrome in international therapy guidelines: A comparative analysis. Pharmacopsychiatry. 2020, 53:51-9. 10.1055\/a-1046-1044","journal-title":"Pharmacopsychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016657553","article-title":"Neuroleptic malignant syndrome","volume":"50","author":"Pileggi DJ","year":"2016","unstructured":"Pileggi DJ, Cook AM. Neuroleptic malignant syndrome. Ann Pharmacother. 2016, 50:973-81. 10.1177\/1060028016657553","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1941875210386491","article-title":"Neuroleptic malignant syndrome: A review for neurohospitalists","volume":"1","author":"Berman BD","year":"2011","unstructured":"Berman BD. Neuroleptic malignant syndrome: A review for neurohospitalists. Neurohospitalist. 2011, 1:41-7. 10.1177\/1941875210386491","journal-title":"Neurohospitalist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802200606","article-title":"Neuroleptic rechallenge after neuroleptic malignant syndrome: Case report and literature review","volume":"22","author":"Wells AJ","year":"1988","unstructured":"Wells AJ, Sommi RW, Crismon ML. Neuroleptic rechallenge after neuroleptic malignant syndrome: Case report and literature review. Drug Intell Clin Pharm. 1988, 22:475-80. 10.1177\/106002808802200606","journal-title":"Drug Intell Clin Pharm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i2.625","article-title":"Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report","volume":"10","author":"Yang CJ","year":"2022","unstructured":"Yang CJ, Chiu CT, Yeh YC, Chao A. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report. World J Clin Cases. 2022, 10:625-30. 10.12998\/wjcc.v10.i2.625","journal-title":"World J Clin Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1721380","article-title":"Dexmedetomidine infusion as a novel supportive therapy for fluphenazine-induced neuroleptic malignant syndrome in a 10-year-old boy: A case report and review of literature","volume":"19","author":"Yu C","year":"2021","unstructured":"Yu C, Kaul R, Ostwani W. Dexmedetomidine infusion as a novel supportive therapy for fluphenazine-induced neuroleptic malignant syndrome in a 10-year-old boy: A case report and review of literature. J Pediatr Neurol. 2021, 19:425-7. 10.1055\/s-0040-1721380","journal-title":"J Pediatr Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000725","article-title":"Successful emergency treatment of refractory neuroleptic malignant syndrome with electroconvulsive therapy and a novel use of dexmedetomidine: A case report from California in the era of COVID-19","volume":"37","author":"Rajan R","year":"2021","unstructured":"Rajan R, Sage M. Successful emergency treatment of refractory neuroleptic malignant syndrome with electroconvulsive therapy and a novel use of dexmedetomidine: A case report from California in the era of COVID-19. J ECT. 2021, 37:71-3. 10.1097\/YCT.0000000000000725","journal-title":"J ECT"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers JP","year":"2023","unstructured":"Rogers JP, Oldham MA, Fricchione G, et al.. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023, 37:327-69. 10.1177\/02698811231158232","journal-title":"J Psychopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191913-severe-recurrence-of-neuroleptic-malignant-syndrome-usefulness-of-dexmedetomidine-for-antipsychotic-withdrawal","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:18Z","timestamp":1707509358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191913-severe-recurrence-of-neuroleptic-malignant-syndrome-usefulness-of-dexmedetomidine-for-antipsychotic-withdrawal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.47088","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,15]]}}}